It’s a busy schedule of community appearances for Rep. Barbara Lee, D-Oakland.
On Saturday, Lee met in Berkeley with volunteers receiving training to help clean up of Bay Area shorelines after the disastrous Cosco Busan oil spill. Yesterday morning, Lee spoke at a rally and “die-in” in downtown Oakland’s Frank Ogawa Plaza aimed at urging China — host of the 2008 Summer Olympics, and Sudan’s chief diplomatic sponsor — to force an end to ongoing violence and humanitarian crisis in Darfur; Lee in May had co-sponsored a resolution urging just such action.
Tomorrow — Tuesday, Nov. 20 — Lee will host an American Diabetes Month roundtable discussion on newly released information on the potential for false diabetes test results among people of African, Mediterranean, or Southeast Asian heritage using the common “A1C” diabetes test. At a March subcommittee meeting, Lee had asked a National Institute on Diabetes and Digestive Kidney Diseases (NIDDK) doctor about the test’s veracity; further research after that hearing found the A1C test was potentially ineffective for ethnic groups with variant strains of hemoglobin.
“The fact that a commonly used diabetes test is unreliable among people of African, Mediterranean, or Southeast Asian heritage, speaks volumes about the need to re-evaluate our health systems and our approach to diagnosis, care and treatment to meet the unique needs of minority communities,” said Lee.
She’ll be joined at tomorrow’s event by Dr. Tolbert Small of East Oakland’s Harriet Tubman Medical Office; Jeffrey Oxendine, an associate dean in the University of California Berkeley’s School of Public Health; NIDDK representative Anita Wilkerson and Dr. Bertram Lubin, president and medical research director at the Children’s Hospital Oakland Research Institute, as well as by representatives from local health clinics and faith communities. It’s 10 a.m. to 11:30 a.m. in conference room 3B at the West Oakland Health Center, 700 Adeline St.